儿科肾脏病学中的生物标志物——从床边到实验室再回到床边
Biomarkers in Pediatric Nephrology-From Bedside to Bench and Back Again.
作者信息
Musiał Kinga
机构信息
Department of Pediatric Nephrology, Wrocław Medical University, Borowska 213, 50-556 Wrocław, Poland.
出版信息
J Clin Med. 2022 Oct 7;11(19):5919. doi: 10.3390/jcm11195919.
Abstract
The progress in biomarker research is characterized by the perpetual quest for parameters that fulfill the strict criteria of sensitivity, specificity, ease and speed in performance and cost-effectiveness [...].
摘要
生物标志物研究的进展特点是不断寻求符合敏感性、特异性、操作简便性和速度以及成本效益等严格标准的参数[……]。
相似文献
1
Biomarkers in Pediatric Nephrology-From Bedside to Bench and Back Again.儿科肾脏病学中的生物标志物——从床边到实验室再回到床边
J Clin Med. 2022 Oct 7;11(19):5919. doi: 10.3390/jcm11195919.
2
From bedside to bench and back: Translating ASD models.从床边到实验台再回归床边：转化孤独症谱系障碍模型
Prog Brain Res. 2018;241:113-158. doi: 10.1016/bs.pbr.2018.10.003. Epub 2018 Nov 7.
3
Tissue engineering: from the bedside to the bench and back to the bedside.组织工程：从床边到实验台，再回到床边。
Pediatr Surg Int. 2020 Oct;36(10):1123-1133. doi: 10.1007/s00383-020-04722-z. Epub 2020 Jul 30.
4
YKL-40 in dialysis patients: another candidate in the quest for useful biomarkers in nephrology.透析患者的 YKL-40：肾病学中寻找有用生物标志物的又一个候选者。
Kidney Int. 2018 Jan;93(1):21-22. doi: 10.1016/j.kint.2017.08.009.
5
Perspectives: From Bedside to Bench.视角：从床边到实验室
Am J Physiol Renal Physiol. 2015 Jul 1;309(1):F1. doi: 10.1152/ajprenal.00180.2015. Epub 2015 Apr 29.
6
Integration of Single-Center Data-Driven Vital Sign Parameters into a Modified Pediatric Early Warning System.将单中心数据驱动的生命体征参数整合到改良的儿科早期预警系统中。
Pediatr Crit Care Med. 2017 May;18(5):469-476. doi: 10.1097/PCC.0000000000001150.
7
The long journey of cancer biomarkers from the bench to the clinic.癌症生物标志物从实验室到临床的漫长旅程。
Clin Chem. 2013 Jan;59(1):147-57. doi: 10.1373/clinchem.2012.184614. Epub 2012 Sep 27.
8
Biomarkers: from bedside to bench and back again.
Am J Geriatr Psychiatry. 2002 Nov-Dec;10(6):644-5.
9
本文引用的文献
1
Applications of cardiac biomarkers in chronic kidney disease.心脏标志物在慢性肾脏病中的应用。
Curr Opin Nephrol Hypertens. 2022 Nov 1;31(6):534-540. doi: 10.1097/MNH.0000000000000829. Epub 2022 Aug 4.
2
Plasma biomarkers associated with survival and thrombosis in hospitalized COVID-19 patients.与住院 COVID-19 患者生存和血栓形成相关的血浆生物标志物。
Int J Hematol. 2022 Dec;116(6):937-946. doi: 10.1007/s12185-022-03437-2. Epub 2022 Aug 22.
3
Understanding COVID-19-associated coagulopathy.理解 COVID-19 相关的凝血异常。
Nat Rev Immunol. 2022 Oct;22(10):639-649. doi: 10.1038/s41577-022-00762-9. Epub 2022 Aug 5.
4
Biomarkers in Nephropathic Cystinosis: Current and Future Perspectives.遗传性胱氨酸病的生物标志物：现状和未来展望。
Cells. 2022 Jun 4;11(11):1839. doi: 10.3390/cells11111839.
5
Proteomics and Extracellular Vesicles as Novel Biomarker Sources in Peritoneal Dialysis in Children.蛋白质组学和细胞外囊泡作为儿童腹膜透析中新型生物标志物来源。
Int J Mol Sci. 2022 May 18;23(10):5655. doi: 10.3390/ijms23105655.
6
Neonatal Acute Kidney Injury.新生儿急性肾损伤
Front Pediatr. 2022 Apr 7;10:842544. doi: 10.3389/fped.2022.842544. eCollection 2022.
7
Artificial intelligence in glomerular diseases.人工智能在肾小球疾病中的应用。
Pediatr Nephrol. 2022 Nov;37(11):2533-2545. doi: 10.1007/s00467-021-05419-8. Epub 2022 Mar 10.
8
Comparing accuracy of urinary biomarkers in differentiation of ureteropelvic junction obstruction from nonobstructive dilatation in children.比较尿生物标志物在鉴别儿童肾盂输尿管连接部梗阻与非梗阻性扩张中的准确性。
Pediatr Nephrol. 2022 Oct;37(10):2277-2287. doi: 10.1007/s00467-022-05488-3. Epub 2022 Mar 3.
9
Advances in proteomic profiling of pediatric kidney diseases.儿科肾脏疾病蛋白质组学分析的进展。
Pediatr Nephrol. 2022 Oct;37(10):2255-2265. doi: 10.1007/s00467-022-05497-2. Epub 2022 Feb 26.
10
Diagnostic and Prognostic Biomarkers of Coronavirus Disease 2019 in Children.儿童 2019 冠状病毒病的诊断和预后生物标志物。
J Trop Pediatr. 2022 Feb 3;68(2). doi: 10.1093/tropej/fmac003.
Zotero 插件